A pharmacy advertises COVID -19 testing and a vaccine on September 04, 2025 in the Brooklyn borough of New York City. Spencer Platt/Getty Images/AFP(Getty Images via AFP) Federal health officials are ...

*The U.S. Food and Drug Administration (FDA) will share information next week pointing to a possible connection between COVID-19 shots and the deaths of 25 children, according to a source speaking to ...

Professor Jessica Hassel from the University Hospital Heidelberg will present the results on October 20 during the melanoma and skin tumors session. Additionally, the company will present a poster on ...

The Food and Drug Administration (FDA) plans to present data next week that it claims links COVID vaccines to the deaths of 25 children. This information will be shared at the Centers for Disease ...

(Bloomberg) -- A popular Chinese financial data provider has halted releasing figures tracking local bond flows, according to some of the firm’s clients, as a rally in the country’s stock market fuels ...

Neoclouds have emerged as the fastest-growing niche within the data center landscape, with the sector’s revenues nearly doubling on an annual basis. But these AI cloud specialists also carry ...

WILMINGTON, Del., September 10, 2025--(BUSINESS WIRE)--Today Incyte (Nasdaq:INCY) announced that it will present new data from its dermatology portfolio at the European Association of Dermatology and ...

CAMBRIDGE, Mass., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

REDWOOD CITY, Calif. - Corcept Therapeutics Incorporated (NASDAQ:CORT), a pharmaceutical company with a market capitalization of $8.43 billion and impressive revenue growth of 25.7% over the last ...

Longer-term data to be presented at the 5th International ATTR Amyloidosis Meeting for Patients and Doctors on September 25 highlighting up to three years of patient follow-up and additional insight ...

LONDON and GAITHERSBURG, Md., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering ...

Presentation to highlight preclinical data from the company’s lead cell therapy, ERNA-101, demonstrating potential to reprogram the ovarian tumor microenvironment and advance toward clinical trials ...